APA (7th ed.) Citation

Yuanchun Fan, Huimin Cheng, Yueping Liu, Shihao Liu, Scott Lowe, Yaru Li, . . . Hui Zhang. (2022). Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yuanchun Fan, et al. Metformin Anticancer: Reverses Tumor Hypoxia Induced by Bevacizumab and Reduces the Expression of Cancer Stem Cell Markers CD44/CD117 in Human Ovarian Cancer SKOV3 Cells. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Yuanchun Fan, et al. Metformin Anticancer: Reverses Tumor Hypoxia Induced by Bevacizumab and Reduces the Expression of Cancer Stem Cell Markers CD44/CD117 in Human Ovarian Cancer SKOV3 Cells. Frontiers Media S.A., 2022.